Soft gel capsules improve melatonin’s bioavailability in humans

Bibliography

• Fasinu P, Pillay V, Ndesendo VM, et al. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm Drug Dispos 2011;32:185-209
   PubMed Web of Science ®Google Scholar
• Malhotra S, Sawhney G, Pandhi P. The therapeutic potential of melatonin: a review of the science. MedGenMed 2004;6(2):46
   PubMedGoogle Scholar
• Lieberman HR. Behavior, sleep and melatonin. J Neural Transm Suppl 1986;21:233-41
   PubMedGoogle Scholar
• Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev 2002(2):CD001520
   Google Scholar
• Alvarez B, Dahlitz MJ, Vignau J, et al. The delayed sleep phase syndrome: clinical and investigative findings in 14 subjects. J Neurol Neurosurg Psychiatry 1992;55(8):665-70
   PubMed Web of Science ®Google Scholar
• Gringras P, Gamble C, Jones AP, et al. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ 2012;345:e6664
   PubMedGoogle Scholar
• Karasek M, Reiter RJ. Melatonin and aging. Neuro Endocrinol Lett 2002;23(1):14-16
   PubMedGoogle Scholar
• Lewy AJ. Melatonin and human chronobiology. Cold Spring Harb Symp Quant Biol 2007;72:623-36
   PubMedGoogle Scholar
• Cutando A, Aneiros-Fernández J, Aneiros-Cachaza J, et al. Melatonin and cancer: current knowledge and its application to oral cavity tumours. J Oral Pathol Med 2011;40(8):593-7
   PubMed Web of Science ®Google Scholar
• Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, et al. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Investig Drugs 2012;21(6):819-31
   PubMed Web of Science ®Google Scholar
• Lissoni P, Rovelli F. Principles of psychoneuroendocrinoimmunotherapy of cancer. Immunotherapy 2012;4(1):77-86
   PubMed Web of Science ®Google Scholar
• Zha L, Fan L, Sun G, et al. Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis. J Pineal Res 2012;52(3):322-31
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Manchester LC, et al. Melatonin and reproduction revisited. Biol Reprod 2009;81(3):445-56
   PubMed Web of Science ®Google Scholar
• Silman RE, Leone RM, Hooper RJ, et al. Melatonin, the pineal gland and human puberty. Nature 1979;282(5736):301-3
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Korkmaz A, et al. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum Reprod Update 2014;20(2):293-307
   PubMed Web of Science ®Google Scholar
• Vanderlelie J, Venardos K, Clifton VL, et al. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005;26(1):53-8
   PubMed Web of Science ®Google Scholar
• Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, et al. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012;351(2):152-66
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Terron MP, et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007;42(1):28-42
   PubMed Web of Science ®Google Scholar
• Mayo JC, Sainz RM, Antoli I, et al. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002;59(10):1706-13
   PubMed Web of Science ®Google Scholar
• Slominski A, Wortsman J, Tobin DJ. The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J 2005;19(2):176-94
   PubMed Web of Science ®Google Scholar
• Kim TK, Kleszczynski K, Janjetovic Z, et al. Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J 2013;27(7):2742-55
   PubMed Web of Science ®Google Scholar
• Slominski A, Tobin DJ, Zmijewski MA, et al. Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 2008;19(1):17-24
   PubMed Web of Science ®Google Scholar
• Di WL, Kadva A, Johnston A, et al. Variable bioavailability of oral melatonin. N Engl J Med 1997;336(14):1028-9
   PubMed Web of Science ®Google Scholar
• Lane EA, Moss HB. Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J Clin Endocrinol Metab 1985;61:1214-16
   PubMed Web of Science ®Google Scholar
• Waldhauser F, Waldhauser M, Lieberman HR, et al. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984;39(4):307-13
   PubMed Web of Science ®Google Scholar
• Fourtillan JB, Brisson AM, Gobin P, et al. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin. Biopharm Drug Dispos 2000;21(1):15-22
   PubMed Web of Science ®Google Scholar
• Demuro RL, Nafzinger AN, Blask DE, et al. The absolute bioavailability of oral melatonin. J Clin Pharmacol 2000;40:781-4
   PubMed Web of Science ®Google Scholar
• Brzezinski A. Melatonin in human. N Engl J Med 1997;336:186-95
   PubMed Web of Science ®Google Scholar
• Kopin IJ, Pare CM, Axelrod J, et al. The fate of melatonin in animals. J Biol Chem 1961;236:3072-5
   PubMed Web of Science ®Google Scholar
• Shirui M, Jianming C, Zhenping W, et al. Intranasal administration of melatonin starch microspheres. Int J Pharm 2004;272:37-43
   PubMedGoogle Scholar
• Härtter S, Grözinger M, Weigmann H, et al. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther 2000;67(1):1-6
   PubMed Web of Science ®Google Scholar
• Daya S, Walker RB, Glass BD, Anoopkumar-Dukie S. The effect of variations in pH and temperature on stability of melatonin in aqueous solution. J Pineal Res 2001;31:155-8
   PubMed Web of Science ®Google Scholar
• Gullapalli RP. Soft gelatin capsules (softgels). J Pharm Sci 2010;99(10):4107-48
   PubMed Web of Science ®Google Scholar
• Simonin G, Bru L, Lelievre E, et al. Determination of melatonin in biological fluids in the presence of the melatonin agonist S 20098: comparison of immunological techniques and GC-MS methods. J Pharm Biomed Anal 1999;21:591-601
   PubMed Web of Science ®Google Scholar
• Lissy M, Scallion R, Stiff DD, et al. Pharmacokinetic comparison of an oral diclofenac potassium liquid-filled soft gelatin capsule with a diclofenac potassium tablet. Expert Opin Pharmacother 2010;11(5):701-8
   PubMed Web of Science ®Google Scholar
• Saano V, Paronen P, Peura P, et al. Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 1991;29(10):381-5
   PubMedGoogle Scholar
• Curtis JJ, Barbeito R, Pirsch J, et al. Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients. Am J Kidney Dis 1999;34(5):869-74
   PubMed Web of Science ®Google Scholar
• Pabla D, Akhlaghi F, Zia H. A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry. Eur J Pharm Biopharm 2009;72(1):105-10
   PubMed Web of Science ®Google Scholar